Introduction and Objective: Diabetes technology use is associated with improved type 1 diabetes (T1D) outcomes. Youth with public insurance use less diabetes technology than privately insured peers. After referral for education, barriers prevent successful insulin pump adoption. We executed a Quality Improvement (QI) project to increase the percentage of public insured patients with T1D receiving an insulin pump within 3 months of referral, from 37% to 50% in 15 months. Methods: Patients referred for insulin pump education were tracked from referral to pump utilization.A multidisciplinary team identified key change concepts and tested them through PDSA cycles. Interventions included individualized follow-up with patients who missed scheduled education using phone calls and patient portals, additional RN education sessions, and guided hands-on technology demonstrations. Results: As of November 2025, the percentage of public insured children with T1D utilizing an insulin pump within 3 months of education increased from 33% in Mar 2024 to 68% in Nov 2025 (exceeding our goal of 50%); Fig 1. Conclusion: QI methodology and an intentional focus on health equity enabled our team to customize interventions and continue to work towards increasing insulin pump use among publicly insured youth with T1D. This work demonstrates how tailored, data-driven interventions can reduce disparities in access to diabetes technology to improve chronic disease management in populations historically facing barriers to care. Disclosure A. Cymbaluk: None. K. McNamara: None. C. Byer-Mendoza: None. A.M. Huber: None. C. Demeterco-Berggren: Advisory Panel; Ended; Sanofi. Board Member; Current; Glooko, Inc. Research Support; Ended; Medtronic.
Cymbaluk et al. (Fri,) studied this question.